Capstan Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Capstan Therapeutics's estimated annual revenue is currently $19.2M per year.
- Capstan Therapeutics's estimated revenue per employee is $155,000
- Capstan Therapeutics's total funding is $340M.
Employee Data
- Capstan Therapeutics has 124 Employees.
- Capstan Therapeutics grew their employee count by 12% last year.
Capstan Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | President and CEO | Reveal Email/Phone |
2 | Co-Founder and VP/Head Research | Reveal Email/Phone |
3 | Co-Founder and VP Research | Reveal Email/Phone |
4 | Founding Chief Scientific Officer and EVP R&D | Reveal Email/Phone |
5 | Chief Technology Officer | Reveal Email/Phone |
6 | Chief Financial Officer | Reveal Email/Phone |
7 | Chief Technology Officer | Reveal Email/Phone |
8 | Chief Financial Officer | Reveal Email/Phone |
9 | Founding Chief Scientific Officer and EVP R&D | Reveal Email/Phone |
10 | SVP, Regulatory and Quality | Reveal Email/Phone |
Capstan Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is Capstan Therapeutics?
Capstan is a biotechnology company with a mission to multiply the therapeutic possibilities for patients by developing targeted in vivo RNA technologies. Our CellSeeker™ tLNP platform technology comprises proprietary targeted lipid nanoparticles (tLNP) that are composed of LNPs conjugated with a recombinant protein binder, such as a monoclonal antibody. tLNPs are designed to deliver payloads, including mRNA or gene editing tools, capable of reprogramming specific cell types in vivo. Capstan’s CellSeeker™ technology has the potential to generate transformative therapies with possible applications across a broad range of disease areas, including autoimmune disorders, oncology, fibrosis, and monogenic blood disorders. For more information, please visit www.capstantx.com.
keywords:N/A
$340M
Total Funding
124
Number of Employees
$19.2M
Revenue (est)
12%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in San Diego
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $33.5M | 124 | 6% | N/A |
#2 | $31.1M | 124 | 2% | $313M |
#3 | $40.9M | 124 | -5% | N/A |
#4 | $34.1M | 124 | -22% | N/A |
#5 | $29.9M | 124 | 103% | N/A |